These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 1422579)

  • 1. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.
    Lawson K; Barras M; Zazzi-Sudriez E; Martin DJ; Armstrong JM; Hicks PE
    Br J Pharmacol; 1992 Sep; 107(1):58-65. PubMed ID: 1422579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of several potassium channel openers and glibenclamide on the uterus of the rat.
    Piper I; Minshall E; Downing SJ; Hollingsworth M; Sadraei H
    Br J Pharmacol; 1990 Dec; 101(4):901-7. PubMed ID: 2128195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tracheal relaxation induced by potassium channel opening drugs: its antagonism by adrenergic neurone blocking agents.
    Berry JL; Small RC; Foster RW
    Br J Pharmacol; 1992 Aug; 106(4):813-8. PubMed ID: 1393280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the vascular relaxant effects of ATP-dependent K+ channel openers on aorta and pulmonary artery isolated from spontaneously hypertensive and Wistar-Kyoto rats.
    Kwan YW; To KW; Lau WM; Tsang SH
    Eur J Pharmacol; 1999 Jan; 365(2-3):241-51. PubMed ID: 9988108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potassium channel openers act through an activation of ATP-sensitive K+ channels in guinea-pig cardiac myocytes.
    Escande D; Thuringer D; Le Guern S; Courteix J; Laville M; Cavero I
    Pflugers Arch; 1989 Sep; 414(6):669-75. PubMed ID: 2510125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Similarities in the mechanism of action of two new vasodilator drugs: pinacidil and BRL 34915.
    Cook NS; Quast U; Hof RP; Baumlin Y; Pally C
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):90-9. PubMed ID: 2450263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular pharmacology of ATP-sensitive K+ channels: interactions between glyburide and K+ channel openers.
    Meisheri KD; Khan SA; Martin JL
    J Vasc Res; 1993; 30(1):2-12. PubMed ID: 8435468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of several potassium-channel openers on rat bladder and rat portal vein in vitro.
    Edwards G; Henshaw M; Miller M; Weston AH
    Br J Pharmacol; 1991 Mar; 102(3):679-86. PubMed ID: 1364839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relaxant effects of the potassium channel activators BRL 38227 and pinacidil on guinea-pig and human airway smooth muscle, and blockade of their effects by glibenclamide and BRL 31660.
    Buckle DR; Arch JR; Bowring NE; Foster KA; Taylor JF; Taylor SG; Shaw DJ
    Pulm Pharmacol; 1993 Mar; 6(1):77-86. PubMed ID: 8477155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased vasodilator responsiveness to BRL 34915 in spontaneously hypertensive versus normotensive rats: contrast with nifedipine.
    Falotico R; Keiser J; Haertlein B; Cheung WM; Tobia A
    Proc Soc Exp Biol Med; 1989 Feb; 190(2):179-85. PubMed ID: 2915996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic and pharmacological evaluation of the vasodilator and vasoconstrictor effects of endothelin-1 in rats.
    Le Monnier de Gouville AC; Mondot S; Lippton H; Hyman A; Cavero I
    J Pharmacol Exp Ther; 1990 Jan; 252(1):300-11. PubMed ID: 2405151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels.
    Cavero I; Mondot S; Mestre M
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1261-8. PubMed ID: 2495353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The resistance of some rat cerebral arteries to the vasorelaxant effect of cromakalim and other K+ channel openers.
    McPherson GA; Stork AP
    Br J Pharmacol; 1992 Jan; 105(1):51-8. PubMed ID: 1534504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of responses to cromakalim and pinacidil in smooth and cardiac muscle by use of selective antagonists.
    McPherson GA; Angus JA
    Br J Pharmacol; 1990 Jun; 100(2):201-6. PubMed ID: 2116201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of the effects of potassium channel modulating agents on mouse intestinal smooth muscle.
    Yeung CK; McCurrie JR; Wood D
    J Pharm Pharmacol; 2002 Mar; 54(3):425-33. PubMed ID: 11902810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of rubidium on responses to potassium channel openers in rat isolated aorta.
    Greenwood IA; Weston AH
    Br J Pharmacol; 1993 Aug; 109(4):925-32. PubMed ID: 8401946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of vasorelaxant responses to potassium channel openers by basal nitric oxide in the rat isolated superior mesenteric arterial bed.
    McCulloch AI; Randall MD
    Br J Pharmacol; 1996 Mar; 117(5):859-66. PubMed ID: 8851502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The individual enantiomers of cis-cromakalim possess K+ channel opening activity.
    Quast U; Villhauer EB
    Eur J Pharmacol; 1993 Apr; 245(2):165-71. PubMed ID: 8491256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KATP channel openers reverse immune complex-induced airways hyperreactivity independently of smooth muscle relaxation.
    Buchheit KH; Hofmann A
    Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):355-61. PubMed ID: 8878067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. K+ channel opening mediates the vasorelaxant effects of nicorandil in the intact vascular system.
    Cavero I; Pratz J; Mondot S
    Z Kardiol; 1991; 80 Suppl 7():35-41. PubMed ID: 1838848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.